Avadel Pharmaceuticals plc Overview

Avadel Pharmaceuticals plc Operating Income

Operating Income for AVDL.

Quarterly Operating Income

$1.94M

↓ 692.35% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$4.52M

↓ 107.07% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin